994 related articles for article (PubMed ID: 27425887)
1. The blood-brain barrier in Alzheimer's disease.
Zenaro E; Piacentino G; Constantin G
Neurobiol Dis; 2017 Nov; 107():41-56. PubMed ID: 27425887
[TBL] [Abstract][Full Text] [Related]
2. Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease.
Li YY; Guo DD; Duan RN; Li Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):136. PubMed ID: 38682184
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
5. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
6. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
7. Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer's Disease Brains.
Soto-Rojas LO; Campa-Córdoba BB; Harrington CR; Salas-Casas A; Hernandes-Alejandro M; Villanueva-Fierro I; Bravo-Muñoz M; Garcés-Ramírez L; De La Cruz-López F; Ontiveros-Torres MÁ; Gevorkian G; Pacheco-Herrero M; Luna-Muñoz J
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915754
[TBL] [Abstract][Full Text] [Related]
8. Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease.
Zhao M; Jiang XF; Zhang HQ; Sun JH; Pei H; Ma LN; Cao Y; Li H
Ageing Res Rev; 2021 Dec; 72():101483. PubMed ID: 34610479
[TBL] [Abstract][Full Text] [Related]
9. Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease.
Huang Z; Wong LW; Su Y; Huang X; Wang N; Chen H; Yi C
Front Neuroendocrinol; 2020 Oct; 59():100857. PubMed ID: 32781194
[TBL] [Abstract][Full Text] [Related]
10. Locus Coeruleus and neurovascular unit: From its role in physiology to its potential role in Alzheimer's disease pathogenesis.
Giorgi FS; Galgani A; Puglisi-Allegra S; Limanaqi F; Busceti CL; Fornai F
J Neurosci Res; 2020 Dec; 98(12):2406-2434. PubMed ID: 32875628
[TBL] [Abstract][Full Text] [Related]
11. Amyloid Beta-Mediated Neurovascular Toxicity in Alzheimer's Disease.
Banerjee S; Banerjee S
Methods Mol Biol; 2024; 2761():355-372. PubMed ID: 38427250
[TBL] [Abstract][Full Text] [Related]
12. Imaging of Leukocyte Trafficking in Alzheimer's Disease.
Pietronigro E; Zenaro E; Constantin G
Front Immunol; 2016; 7():33. PubMed ID: 26913031
[TBL] [Abstract][Full Text] [Related]
13. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J
Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560
[TBL] [Abstract][Full Text] [Related]
14. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
[TBL] [Abstract][Full Text] [Related]
15. Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer's Disease.
Huang W; Xia Q; Zheng F; Zhao X; Ge F; Xiao J; Liu Z; Shen Y; Ye K; Wang D; Li Y
J Alzheimers Dis; 2023; 94(s1):S335-S354. PubMed ID: 36683511
[TBL] [Abstract][Full Text] [Related]
16. Effects of Voluntary Physical Exercise on the Neurovascular Unit in a Mouse Model of Alzheimer's Disease.
Andrade-Guerrero J; Orta-Salazar E; Salinas-Lara C; Sánchez-Garibay C; Rodríguez-Hernández LD; Vargas-Rodríguez I; Barron-Leon N; Ledesma-Alonso C; Diaz-Cintra S; Soto-Rojas LO
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446312
[TBL] [Abstract][Full Text] [Related]
17. Blockade of α4 integrins reduces leukocyte-endothelial interactions in cerebral vessels and improves memory in a mouse model of Alzheimer's disease.
Pietronigro E; Zenaro E; Bianca VD; Dusi S; Terrabuio E; Iannoto G; Slanzi A; Ghasemi S; Nagarajan R; Piacentino G; Tosadori G; Rossi B; Constantin G
Sci Rep; 2019 Aug; 9(1):12055. PubMed ID: 31427644
[TBL] [Abstract][Full Text] [Related]
18. Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease.
Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Sarkar S
Neuroscience; 2020 Aug; 440():48-55. PubMed ID: 32450297
[TBL] [Abstract][Full Text] [Related]
19. The role of neurovascular unit damage in the occurrence and development of Alzheimer's disease.
Liu X; Hou D; Lin F; Luo J; Xie J; Wang Y; Tian Y
Rev Neurosci; 2019 Jul; 30(5):477-484. PubMed ID: 30530893
[TBL] [Abstract][Full Text] [Related]
20. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
